Title for MeetingAbstracts
Alphabetical listing of titles
M&E for all: A multi-sectoral approach to monitoring and evaluation of HIV/AIDS programs in Rwanda.
M*A*P--prevention among youth in pop concerts: a new concept.
M+C Becomes MA: Will Past be Prologue?
M-CSF modulation of CD4 expression in human macrophages (M/M) reduce the anti-HIV activity of drugs that inhibit virus binding.
M-CSF production and HIV-1 replication in human macrophages following in vitro treatment with recombinant human IL-2.
M-tropic HIV-1 replication in the human fetal thymus organ culture model system suggests utilization of an unusual HIV co-receptor.
M-tropic HIV-1 strains are extremely sensitive to inhibition by RANTES. Sensitivity of T-tropic strains to RANTES is donor cell dependent.
M. avium complex (MAC): low frequency of natural resistance and absence of selection for resistant bacilli with rifabutin.
M. fascicularis and M. nemestrina are susceptible to infection with a distinct HIV-2 isolate and infectious clone of HIV-2 (GB122).
M. genavense, a novel Mycobacterium causing disseminated infections in HIV seropositive patients.
M. tuberculosis (TB) among children reported with HIV/AIDS, U.S.
M. tuberculosis in a group of 169 HIV-1 seropositives at Pune, India.
M. tuberculosis-derived arabinomannan (Z-100) enhances the anti-HIV activity of zidovudine (AZT) in cultures of human peripheral blood mononuclear cells.
M.O.R.E. Connections: Innovative Substance Abuse Treatment for Ex-Offenders of Color.
M184V Independent Resistance to Abacavir Detected by HIV Phenotypic Assay.
M184V mutation is not predictive of therapeutic failure to d4T/3TC combination.
M184V Selection in Suppressed Subjects at Week 24 May Not Be Associated with Treatment Outcome (NZTA4002).
MAB labelled liposomes as vehicles for AZT: choice of specific monoclonal antibodies for infected cells.
MAC infections in AIDS: comparative yield of diagnostic tests.
MAC or lymphoma? Paradoxical treatment response with highly active antiretroviral therapy.
MAC prophylaxis with clarithromycin 500 mg bid in patients with AIDS.
MAC prophylaxis with clarithromycin 500 mg daily.
MAC prophylaxis: application of guidelines.
MAC: pathogenesis and treatment.
Macaca nemestrina: a new primate model for HIV-1 infection.
Macaque Breast-feeding Model Reveals Rapid Dissemination of SIV Following Oral Inoculation.
Macaque resistance to mucosal SIV infection is not associated with changes in CCR5 coding sequence.
Macaques Inoculated with a Pathogenic Simian-Human Immunodeficiency Virus Develop Disruption of the Blood-brain Barrier Early after Inoculation.
MacCytokine: an interactive, user-friendly computer data base on the cytokines.
Macedonian Mass Media: an analysis of HIV/AIDS and mobility issues in 2002.